PRO MEDICUS LIMITED — Director's Dealing 2025

Mar 11, 2025

Appendix 3Y Change of Director’s Interest Notice

Listing Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of entity Pro Medicus Limited ABN 25 006 194 752

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

irector for the purposes of section 205G of	the Corporations Act.
Name of Director	Anthony GLENNING
Date of last notice	19 March 2020

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

==> picture [433 x 317] intentionally omitted <==

----- Start of picture text ----- Direct or indirect interest IndirectNature of indirect interest Ordinary fully paid shares in Pro Medicus(including registered holder) Limited held by the Anthony GlenningNote: Provide details of the circumstances giving rise to the relevantinterest. Superannuation Fund of which the Director isa Trustee and MemberDate of change 12 March 2025No. of securities held prior to change 9,525Class Ordinary sharesNumber acquired 50 ordinary sharesNumber disposed NilValue/Consideration $219.5990 per shareNote: If consideration is non-cash, provide details and estimated valuationNo. of securities held after change 9,575 ordinary sharesNature of change On market purchaseExample: on-market trade, off-market trade, exercise of options, issue ofsecurities under dividend reinvestment plan, participation in buy-back----- End of picture text -----

• See chapter 19 for defined terms.

11/3/2002

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

==> picture [434 x 315] intentionally omitted <==

----- Start of picture text ----- Detail of contract N/ANature of interest N/AName of registered holder N/A(if issued securities)Date of change N/ANo. and class of securities to which N/Ainterest related prior to changeNote: Details are only required for a contract in relationto which the interest has changedInterest acquired N/AInterest disposed N/AValue/Consideration N/ANote: If consideration is non-cash, provide details and anestimated valuationInterest after change N/A----- End of picture text -----

Part 3 –[+] Closed period

Were the interests in the securities or contracts detailedabove traded during a+closed period where prior writtenclearance was required?	No
If so, was prior written clearance provided to allow thetrade to proceed during this period?	N/A
If prior written clearance was provided, on what date wasthis provided?	N/A

For and on behalf of Pro Medicus Limited

==> picture [124 x 32] intentionally omitted <==

Danny English Company Secretary 12 March 2025

• See chapter 19 for defined terms.

Appendix 3Y Page 2

11/3/2002